ketoconazole has been researched along with Hypercoagulability in 2 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Excerpt | Relevance | Reference |
---|---|---|
"Cushing's syndrome is known to present with a characteristic set of clinical manifestations and complications, well described in literature." | 1.51 | Arterial thrombosis as primary presentation of endogenous Cushing's syndrome. ( Alexander, V; Carey, RA; Dasgupta, R; Koshy, M, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alexander, V | 1 |
Koshy, M | 1 |
Dasgupta, R | 1 |
Carey, RA | 1 |
van der Pas, R | 1 |
de Bruin, C | 1 |
Leebeek, FW | 1 |
de Maat, MP | 1 |
Rijken, DC | 1 |
Pereira, AM | 1 |
Romijn, JA | 1 |
Netea-Maier, RT | 1 |
Hermus, AR | 1 |
Zelissen, PM | 1 |
de Jong, FH | 1 |
van der Lely, AJ | 1 |
de Herder, WW | 1 |
Lamberts, SW | 1 |
Hofland, LJ | 1 |
Feelders, RA | 1 |
1 trial available for ketoconazole and Hypercoagulability
Article | Year |
---|---|
The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy.
Topics: Adult; Aged; Blood Coagulation; Blood Coagulation Factors; Cabergoline; Dopamine Agonists; Drug Moni | 2012 |
1 other study available for ketoconazole and Hypercoagulability
Article | Year |
---|---|
Arterial thrombosis as primary presentation of endogenous Cushing's syndrome.
Topics: Adrenocorticotropic Hormone; Adult; Anticoagulants; Aortic Diseases; Celiac Artery; Computed Tomogra | 2019 |